Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
C. Wang, K. Kaur, C. Xu, Y. Abu-Amer, G. Mbalaviele
This study shows doxorubicin causes bone loss via inflammasome activation, leading to pyroptosis and NETosis, and identifies AIM2 and NLRP3 as key mediators.
bioRxiv · Oct 6, 2023Cell Biology